Upon entering the host cell's cytoplasn, the 
oligoproline stretches In ActA, a bacterial surface protein necessary for Lsteria-induced actin aemby. Over an estimated intracellular concentration range of 80 nM to 0.8 sAM, this e rapidly blocks the formation ofthe actin-filament tails and arrests intracellular bacterial motility. Over the same time scale and concentration range, introduction of the ActA analoue also causes host cell membrane retraction. Dodipyphalacidin ining reveals that mcroinjection of the ActA analogue results in massive retraction of the actin cyteskeleton.
Micronjection of 1-20 JAM poly(L-prollne) (inhtellular concentration) fails to block Listeria intracellular movement or polar actin-fllament assembly. As observed with ActA, however, poly(L-proline) does cause membrane traction. Our findings demonstrate the efficacy of low molecular weight peptdes in efforts to dIsnguh meaisic feate hi Litea motil and PtK2 host cell membrane reorgan on. These observations also suggest that a cytoskeletal component senitive to specific oligoproline peptdes may participate in proteinprotein iteractions essential for both of these actin-aciated processes.
The intracellular pathogen Listeria monocytogenes has generated considerable interest among contractile protein investigators because of this bacterium's ability to induce directional host-cell actin assembly that propels the bacterium rapidly through the cytoplasm (1) (2) (3) . This organism is capable of escaping from the phagolysosome and replicating in the host cell (4) (5) (6) (7) (8) . Intracellular movement allows the bacteria to migrate to the periphery of the cytoplasm where they form filopods laden with bacteria, which are thought to be ingested by adjacent host cells. This overall process allows Listeria to spread from cell to cell without ever coming in contact with the extracellular milieu, enabling this pathogen to circumvent the harmful consequences of the host's humoral immune defenses.
All evidence indicates that formation of polar actinfilament structures is required for Listeria intracellular movement and cell-to-cell spread. Time-lapse video and studies using a caged actin monomer probe indicate that each polar actin structure becomes anchored in the cytoplasm (9, 10), acting as a platform that creates a physical boundary that confines the bacterium to forward movement (11) . New actin monomers add to the bacterial-actin platform interface as the filamentous actin structure progressively elongates, forcing the bacterium to move in a forward direction (9) . Cytochalasin D blocks further elongation of these actin structures, results in marked shortening of the tails, and stops both bacterial intracellular movement (9) and cell-to-cell spread (1) .
Unlike pseudopod and lamellipod formation (12) , Listeria provide a simpler model for understanding actin-based motility. Since actin assembly is induced only after the bacterium is intracellular, the complex events associated with host membrane receptor occupancy are bypassed. Nonetheless, the same proteins thought to play important roles in controlling interactions ofactin filaments in the peripheral cytoplasm of motile cells are also found in the Listeria-induced actin structures, including a-actinin (2) , tropomyosin (9) , and ABP-280 (J. M. Sanger, B. Mittal, F.S.S., and J. W. Sanger, unpublished data).
How then do Listeria induce the polymerization of actin filaments at such discrete sites? ActA, a bacterial protein containing a cluster of several oligoproline stretches, is absolutely required for Listeria-induced actin assembly (13, 14) . Despite the presence of ActA on its surface, when this bacterium is combined with purified actin monomers, actin assembly is not stimulated (15) . It has also been found that ActA fails to bind to globular actin (13) . Therefore, ActA must stimulate actin assembly by binding to, and perhaps activating, one or more of the host cell's actin regulatory protein(s).
To explore the possibility that the polyproline repeats in ActA (13) Purified actin was conjugated with pyrene and actin assembly was monitored by fluorescence intensity (16) . Profilin-actin complexes were purified from calf spleen by using poly(L-proline) affinity chromatography (17) . Solutions containing purified profilin-actin complexes and ActA peptide in S2 buffer (10 mM we added a cysteine residue at the N terminus for future conjugation studies.
In Fig. 1 , multiple bacteria can be seen migrating in a PtK2 cell, and each displays a trailing phase-dense rocket tail. The arrowhead points to a single bacterium enlarged in the lower montage. Bacteria eventually reached the peripheral cytoplasm where they protruded outwardly from the peripheral cytoplasm to form filopodia. A number of organisms were seen in such filopods (see in the lower left ofthe larger panels of disassembly is 70-80 s (9), tails would be expected to persist for brief periods after movement ceases if the ActA peptide does not affect actin depolymerization.
The effects of microinjection of ActA peptide on bacterial motility and rocket tail length were also quantified by direct measurement. The speeds of bacterial movement in PtK2 cells during these experiments varied from 0.05 ,um/s to 0.15 ,utm/s. In all instances, after microinjection of ActA peptide (10 pg/mi, needle concentration), bacterial intracellular migration was arrested. The speed of the particular bacterium designated by the arrowhead in Fig. 1 was determined at each time. Prior to the microinjection of the ActA peptide, the migration rate yarned between 0.11 and 0.08 jan/s. Similarly, the length of the phase-dense tail remained relatively constant varying between 2.2 and 2.8 jFm. On addition ofpeptide, both the rate of bacterial migration and tail length rapidly decreased to 0 (Fig. 2 A and B) .
We also explored the concentration dependence of ActA peptide inhibition. Microinjection of a lower concentration of the ActA peptide (1 pg/mi; estimated intracellular concentration, 80 nM) into infected PtK2 cells also caused the rapid cessation of bacterial movement and the dissolution of the phase-dense rocket tails within 30-60 s (see Fig. 2C ). A needle concentration of 0.1 pg/mi (estimated intracellular concentration, 8 nM) generally failed to impair Listeria movement. Repeated microinjection resulted in the intracellular accumulation of the peptide that resulted in effects identical to single injections of higher concentrations of the peptide (see Fig. 2D ). Membrane retraction was also found to be concentration dependent. Microinjection of a higher concentration (1 mg/ ml, needle concentration; yielding an estimated intracellular concentration of 8 ,uM) resulted in the instantaneous retraction of the peripheral membrane and the cessation of all bacterial movement. Some segments of the membrane remained adherent to the surface resulting in some fragmentation of the peripheral membrane and cytoplasm. Microinjection of a lower concentration of the ActA peptide (1 pg/ml) into infected PtK2 cells caused peripheral membrane retraction of a similar magnitude (16-17 pum) to that observed at 10 ,ug/ml (Fig. 3) . Host-cell membrane retraction, however, was not generally associated with the membrane fragmentation consistently noted with higher concentrations of ActA peptide (compare Fig. 1, 205 s, to Fig. 3B) .
Staining with the filamentous actin probe bodipy-phallacidin revealed marked changes in the actin-filament morphology after microinjecting ActA analogue (Fig. 4) . Before microinjection typical actin-filament rocket tails and stress fibers were seen (Fig. 4A) . Approximately 10 minaftermicroinjection with ActA peptide (needle concentration, 10 Ag/ml), phallacidinstained rocket tails and stress fibers were no longer seen (Fig.  4B) . The edge of the microinjected cell exhibits increased fluorescence, suggesting actin filaments have accumulated near the retracting membrane.
ActA analogue added to the extracellular medium at a much higher concentration (final concentration, 25 pM) failed to cause membrane retraction, indicating that the The ActA analogue has two important structural features: (i) it contains a string of four prolines and (ii) the peptide is bordered by negatively charged groups (Asp and Glu). It is noteworthy that poly(L-proline) fails to block Listeria movement, suggesting stretches of oligoproline alone cannot effectively compete with the bacterial product responsible for inducing actin assembly. At high intracellular concentrations, however, microinjection of this polypeptide did result in membrane retraction. Apparently, peripheral membrane spreading and bacterial intracellular movement can be independently inhibited, and this finding opens the way for further mechanistic exploration of these processes. The poly(Lproline) experiments also indicate that ActA-mediated inhibition ofListeria movement is unlikely to be secondarily caused by fragmentation of the host-cell peripheral membrane.
Although we had anticipated that microinjection of the ActA peptide analogue should affect the actin-rich Listeria rocket tails, much to our surprise, the host cell cytoplasm was also reorganized over the same concentration range of these agents. In retrospect, this finding should have been anticipated if Listeria motility reflects the salient features of actin-based host-cell motility. This peptide analogue is likely to compete with an oligoproline-containing membrane-bound protein involved in regulating host-cell actin assembly at the peripheral membrane.
We still cannot present a complete model for how ActA and a putative oligoproline-rich integral membrane protein might work in a mechanistically analogous manner, but some essential features are emerging. Intracellular bacterial motility appears to occur through the binding ofan actin regulatory protein to one or more of the nonidentical oligoproline repeats on ActA. Likewise, we envision cortical assembly of actin filaments to be the consequence of the anchoring of an actin regulatory protein at oligoproline-containing sites loCell Biology: Southwick and Purich --..L.
calized on the cytoplasmic surface ofthe host cell membrane. To our knowledge, profilin is the only actin-associated protein known to bind to polyproline with high affinity, and we have found significant quantities of profilin in the host PtK2 cells (data not shown) by SDS electrophoretic analysis of proteins adsorbed to poly(L-proline) covalently coupled to Sepharose beads (20) . Profilin also forms a one-to-one complex with monomeric actin and could serve as a carrier protein to transport actin monomers to proline-rich sites on the cell's inner membrane surface, much as actin appears to concentrate on the bacterial surface. Profilin has been found to facilitate nucleotide exchange in vitro (21, 22) ; therefore, this protein may also increase the rate ofconversion of ADPto ATP-actin monomers, a condition that could stimulate actin polymerization to produce the localized expansile forces necessary for motility. We should also note that Goddette and Frieden (23) Our ActA protein analogue may act to displace profilin from both the bacterial cell wall and the inner cell membrane surfaces, thereby blocking assembly of nearby actin filaments. This possibility is supported by filamentous actin staining ofmicroinjected cells with bodipy-phallacidin, which reveals loss of stress fibers and accumulation of filamentous actin near the retracting peripheral membrane. Such disruption of the normal actin filament architecture would also be expected to result in a reduction of peripheral cytoplasm rigidity, in turn leading to retraction of the peripheral membrane. The dramatic retraction of peripheral membranes associated with our ActA analogue suggests that a prolinerich profilin-anchoring protein on the inner surface of cells may play an important role in promoting cortical actin cytoskeleton assembly. Possible candidates include vinculin (24) , human synapsin 1 (25) , and the transmembrane protein CD2 (26) ; each contains oligoproline sequences bordered by negatively charged amino acids in their cytoplasmic domains. In any case, this hypothetical model predicts the basic features of what may be a class of proline-rich membrane proteins and/or peptides with structural elements designed for controlling actin-dependent processes.
